Interestingly, a recent study reported srGAP1 as a candidate susceptibility gene in papillary thyroid carcinoma [20], and several mutations of srGAP1 identified in papillary thyroid carcinoma resulted in severely impaired ability of srGAP1 to inactivate CDC42. This evidence concerns the gene CDC42 and differentiated thyroid carcinoma.